Lesson 5: Acute COPD Exacerbations, Oxygen and Noninvasive Ventilation

Course 04: Respiratory Medicine and Infectious Disease

Lesson 5 of 14. Explore the diagnostic and management frameworks, work through the case, and finish the linked 10-question practice set. Urgent presentations require an emergency-care pathway and review of local professional scope.

Identify the acute syndrome

• An exacerbation involves acute worsening of breathlessness, cough and/or sputum; consider infectious triggers but exclude pneumonia, PE, ACS, heart failure and pneumothorax.
• Record baseline oxygen use, prior admissions, need for noninvasive ventilation, chronic hypercapnia, current sputum purulence and antibiotic exposures.
• Confusion, drowsiness, cyanosis, exhaustion, severe acidosis, shock or inability to protect the airway requires urgent critical-care evaluation.

Clinical treatment fundamentals

• Short-acting bronchodilators and a brief systemic corticosteroid course are frequently used in moderate/severe exacerbations under an appropriate clinician; review adverse effects.
• Antibiotics are not needed for every COPD exacerbation; consider severity, increased sputum purulence/volume, ventilation needs and pneumonia features.
• If risk of CO2 retention, titrate oxygen to an individualized controlled range (commonly 88-92% pending ABG/local protocol) while treating dangerous hypoxemia.

ABG and ventilatory support

• ABG helps characterize pH, PaCO2, PaO2 and acute-on-chronic respiratory acidosis; venous gases may help with pH/CO2 screening but do not replace arterial oxygenation measurement.
• Noninvasive ventilation is important for appropriately selected patients with acute hypercapnic respiratory failure and respiratory acidosis in a monitored setting.
• Severe secretions, inability to protect airway, persistent shock or worsening consciousness can make NIV unsuitable and require immediate specialist airway assessment.

After stabilization

• Review exacerbation triggers, maintenance inhalers, smoking cessation, vaccination, inhaler access, rehabilitation and prompt follow-up.
• Explain when to return for increased dyspnea, new confusion, cyanosis, inability to speak, chest pain or persistent fever.
• Review whether indicated oxygen and ventilation strategies have actually been assessed, rather than extrapolating from one acute reading.

Applied clinical case

A 71-year-old with known COPD is drowsy, tachypneic, hypoxemic and has ABG pH 7.27 with elevated PaCO2.

Clinical self-check

1. How is CO2 retention recognized?
2. What clinical factors limit NIV?
3. Does every exacerbation need an antibiotic?

Current guidance and further learning

• GOLD 2026: COPD report and pocket guide (external)
• Canadian Thoracic Society guideline library (external)

Downloadable learning materials

• Respiratory and Sepsis Emergency Red Flags (PDF)
• Asthma and COPD: Diagnosis, Inhaler Care and Exacerbation Guide (PDF)
• Pneumonia, TB and Viral Infection Decision Guide (PDF)
• Pulmonary Diagnostics and Infectious Safety Reference (PDF)
• Complete Respiratory Medicine Handbook - 14 Lessons (PDF)